Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Perfusion ; 24(2): 135-7, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19654158

ABSTRACT

Heparin-induced thrombocytopenia (HIT) is a serious, antibody-mediated complication of heparin which significantly confers risks of thrombosis and devastating outcomes. Once diagnosed, it requires immediate cessation of heparin and therapy with an alternative anticoagulant. No data are available in the literature on the pathophysiology and clinical implications of performing prolonged extracorporeal membrane oxygenation with a heparin-coated system in a patient with acute HIT treated with bivalirudin.


Subject(s)
Anticoagulants/administration & dosage , Extracorporeal Membrane Oxygenation/methods , Heparin/immunology , Hirudins/administration & dosage , Peptide Fragments/administration & dosage , Thrombocytopenia/therapy , Acute Disease , Aged , Antibodies/adverse effects , Antibodies/immunology , Female , Heparin/administration & dosage , Heparin/adverse effects , Humans , Mitral Valve Insufficiency/surgery , Platelet Count , Recombinant Proteins/administration & dosage , Thrombocytopenia/drug therapy , Thrombocytopenia/immunology
2.
Nutr Metab Cardiovasc Dis ; 19(9): 654-9, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19282159

ABSTRACT

BACKGROUND AND AIMS: Patients with chronic obstructive pulmonary disease (COPD) are at increased atherothrombotic risk. Preliminary findings have suggested that COPD patients may have increased plasma total homocysteine (tHcy), a cardiovascular risk factor often caused by a poor B vitamin status, but plasma levels of such vitamins were not measured. The aim of this study was to investigate hyperhomocysteinaemia in COPD and to determine whether it may be secondary to poor plasma concentrations of B vitamins. METHODS AND RESULTS: We performed a case-control, cross-sectional study of 42 patients with COPD and 29 control subjects. Folate, vitamin B12, vitamin B6, tHcy, renal function, C-reactive protein, blood gases and lipids were measured in patients and controls. COPD patients had higher plasma tHcy (median: 13.9mumol/l, interquantile range [IQR]: 12.1-18.5 versus 11.5, IQR: 10.1-14, p=0.002) and lower circulating folate (median: 2.5ng/ml, IQR: 1.2-3.3 versus 2.8, IQR: 2.1-4 of controls, p=0.03) than controls had. Compared to the control group, COPD was associated with higher tHcy concentrations also after adjusting for smoking, heart failure, renal function and C-reactive protein with logistic regression analysis (OR 1.36, 95% CI 1.06-1.72, p=0.01). In the COPD group, low levels of folate (beta=-0.27, p=0.02) and vitamin B12 (beta=-0.24, p=0.04), and hypertriglyceridaemia (beta=0.580, p<0.0001) were independent predictors of the presence of high tHcy concentrations in a multiple linear regression model (adjusted R(2)=0.522). CONCLUSION: COPD patients have a poor B vitamin status and, as a consequence, increased tHcy. These abnormalities may contribute to the COPD-related atherothrombotic risk.


Subject(s)
Hyperhomocysteinemia/epidemiology , Pulmonary Disease, Chronic Obstructive/epidemiology , Thrombosis/epidemiology , Vitamin B 12 Deficiency/epidemiology , Vitamin B 6 Deficiency/epidemiology , Aged , C-Reactive Protein/metabolism , Case-Control Studies , Cross-Sectional Studies , Female , Folic Acid/blood , Forced Expiratory Volume , Homocysteine/blood , Humans , Hyperhomocysteinemia/blood , Linear Models , Logistic Models , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/blood , Pulmonary Disease, Chronic Obstructive/physiopathology , Risk Factors , Thrombosis/blood , Vital Capacity , Vitamin B 12/blood , Vitamin B 12 Deficiency/blood , Vitamin B 6/blood , Vitamin B 6 Deficiency/blood
3.
Antiviral Res ; 21(4): 317-25, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8215303

ABSTRACT

The authors demonstrate in vitro antiviral activity of a methanolic extract of Combretum micranthum leaves against HSV-1 and HSV-2. This activity is present only in the extract dissolved 7 days before the assay, but not in the freshly prepared extract, thus indicating the presence of inactive precursors which undergo spontaneous transformations into active compounds. The alkaline autooxidation of the methanolic extract promotes this rapid transformation. The precursors have been identified as condensed catechinic tannins, which, under alkaline conditions, suffer rapid cleavage, intramolecular rearrangement to catechinic acid and autooxidation. The alkaline autooxidation products of the methanolic extract of C. micranthum and those of the synthetic catechinic acid show similar I.R. and U.V. absorption curves, as well as similar anti-HSV-1 and -HSV-2 activities. EC50s of catechinic acid autooxidation products against HSV-1 and HSV-2 replication were 2 micrograms/ml and 4 micrograms/ml, respectively, when cell cultures were treated with the compound during virus infection.


Subject(s)
Antiviral Agents/pharmacology , Herpesvirus 1, Human/drug effects , Herpesvirus 2, Human/drug effects , Plant Extracts/pharmacology , Animals , Catechin/pharmacology , Chlorocebus aethiops , Herpes Genitalis/drug therapy , Herpes Simplex/drug therapy , Herpesvirus 1, Human/growth & development , Herpesvirus 2, Human/growth & development , Microbial Sensitivity Tests , Vero Cells , Viral Plaque Assay , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...